Decrease Diagnostic Uncertainty in At-risk Patients Using PCT

Sunday, September 7
Presented by: Thermo Fisher Scientific

• Speaker: James Neuenschwander, MD, FACEP, FASAM
• Time: 2:30pm – 3:15pm
• Location: Exhibit Hall, Expert Theater 1

At-risk patients often present with nonspecific symptoms such as shortness of breath, making their diagnosis challenging. Rapid and accurate diagnoses are of utmost importance. Delayed targeted therapy or inadequate therapy increases the risk of adverse patient outcomes and prolonged hospital stays and increased emergency department crowding. In this presentation Dr. Jim Neuenschwander will examine accelerating treatment decisions and therapy with B·R·A·H·M·S PCT.

Learn how B·R·A·H·M·S PCT can help enhance your clinical decision-making:

• Understand which patients are at risk and why
• Gain insight into how PCT provides proper antibiotic management in at-risk patients.
• Recognize the important nuances when using B·R·A·H·M·S PCT through case study review.